Duyuru • May 06
Dr. Martens plc to Report Fiscal Year 2026 Results on May 19, 2026 Dr. Martens plc announced that they will report fiscal year 2026 results at 6:00 AM, Coordinated Universal Time on May 19, 2026 Duyuru • Nov 21
Dr. Martens plc Declares Interim Dividend, Payable on April 9, 2026 The Board of Dr. Martens plc declared an interim dividend of 0.85 pence per share (Sep 24: 0.85 pence). This will be paid on 9 April 2026 to shareholders on the register as at 6 March 2026. Duyuru • Nov 13
Gen Phoenix and Dr. Martens Celebrate Four Seasons of Waste Reduction with the Launch of the Solar Flare Collection Gen Phoenixand heritage footwear brand Dr. Martens are marking a major milestone in sustainable design: four consecutive seasons of partnership. In celebration of this continued collaboration, which began with the launch of the Genix Nappa collection in 2024, and just in time for the holidays, Dr. Martens is introducing the Solar Flare collection made with Genix Nappa to underscore both brands' shared commitment to long-term impact over one-off pilots and capsules. According to one report, more than 380 brand-innovator collaborations launched in 2023, though many exist as exploratory, pilot or capsule partnerships in nature rather than multi-year programs. Against that backdrop, Gen Phoenix and Dr. Martens stand out as a rare example of a long-term strategic partnership. From its first collection of Genix Nappa reclaimed leather boots in 2024 to the Solar Flare line - which for the very first time includes kids' footwear and bags - the brands have steadily expanded the use of Gen Phoenix's material made from recycled leather fibres across categories while maintaining Dr. Martens' signature durability and comfort. Each season has pushed the boundaries of what heritage design can look like when paired with next-generation materials, furthering a trend Gen Phoenix has pioneered called "luxcycling" turning waste into premium recycled materials without compromising style or quality. Introducing the Next Generation: Solar Flare Kids' Boot: With the launch of the Solar Flare kids' boot, Dr. Martens brings its reclaimed leather innovation to a new audience. The Solar Flare kids boot is crafted from Gen Phoenix's soft and lightweight yet durable Genix Nappa material, with a silver sun, moon and star print across the upper, delivering the same comfort of the original adult Genix Nappa styles. Perfect for growing feet that don't keep still, while aligning with the values of climate conscious shoppers and wearers. Expanding the Circular Revolution: From Boots to Bags: The Solar Flare collection also introduces Dr. Martens' first bag crafted from Gen Phoenix's reclaimed leather material, a category expansion that demonstrates the scalability of Gen Phoenix's circular technology platform. Together, the brands continue to advance their shared goal of achieving net-zero emissions by 2040, showing how material innovation can be woven into iconic design without compromising identity or integrity. To date, Gen Phoenix has helped Dr. Martens: Divert 15 tonnes of leather offcuts from going to waste, roughly the weight of 15 compact cars; Save 693 tCO2e compared to conventional leather, approximately 1.7 million air miles, or 300 round-trip flights from London to New York. These joint efforts from Gen Phoenix and Dr. Martened to transform landfill-destined leather into high-performance Genix Nappa material have resulted in four seasons of durable, comfortable, waste-reducing footwear and accessories. The partnership embodies a simple philosophy: reclaimed leather, remade to last. Duyuru • Jun 18
Dr. Martens plc to Report First Half, 2026 Results on Nov 20, 2025 Dr. Martens plc announced that they will report first half, 2026 results on Nov 20, 2025 Duyuru • Jun 17
Dr. Martens plc, Annual General Meeting, Jul 10, 2025 Dr. Martens plc, Annual General Meeting, Jul 10, 2025. Location: 1 11 hawley crescent, camden, nw1 8np, london United Kingdom Duyuru • Jun 05
Dr. Martens plc Proposes Final Dividend for Fiscal Year 2025, Payable on 8 October 2025 The Board of Dr. Martens plc proposed a final dividend of 1.70 pence, taking the total dividend for fiscal year 2025, including the interim dividend of 0.85 pence, to 2.55 pence (fiscal year 2024: 2.55 pence). This will be paid to shareholders on the register as at 29 August 2025 with payment on 8 October 2025. The proposed dividend is subject to shareholder approval. Duyuru • Feb 12
Dr. Martens plc Announces the Appointments of Robert Hanson and Benoit Vauchy as Non-Executive Directors with Effect from 26 March 2025 Dr. Martens plc announced the appointments of Robert Hanson and Benoit Vauchy as Non-Executive Directors of the Company with effect from 26 March 2025. Robert is an experienced executive with a strong track record of delivering growth at consumer brands. He was CEO of John Hardy and American Eagle Outfitters and also served as EVP Wines and Spirits for Constellation Brands. Prior to this he served for over a decade in senior roles at Levi Strauss & Co, including as President of the Americas division and, latterly, as Global Brand President, Americas. Robert brings a broad, multidisciplinary skillset and significant experience of the North American market combined with global expertise. His prior non-executive experience includes positions on the boards of Canopy Growth, Urban Outfitters and Constellation Brands. He was recently appointed as CEO of US wine company The Duckhorn Portfolio. Benoit is a Partner at the Company's largest investor, global investment firm Permira, where he is a member of the Investment and Executive Committees. He has served on the board of Spanish online travel company eDreams ODIGEO as a Non-Executive Director for a decade, during which time the business has undergone a significant period of transformation. Benoit also serves on the board of Permira Holdings Limited and has previously served on the boards of Universidad Europea, VacanceSelect and Exclusive Networks. He has worked at Permira since 2006, and previously spent six years at JPMorgan in London and Frankfurt. Duyuru • Dec 03
Dr. Martens plc to Report Fiscal Year 2025 Results on Jun 05, 2025 Dr. Martens plc announced that they will report fiscal year 2025 results on Jun 05, 2025 Duyuru • Oct 08
Dr. Martens plc to Report First Half, 2025 Results on Nov 28, 2024 Dr. Martens plc announced that they will report first half, 2025 results on Nov 28, 2024 Duyuru • Jun 14
Dr. Martens plc, Annual General Meeting, Jul 11, 2024 Dr. Martens plc, Annual General Meeting, Jul 11, 2024. Location: holiday inn london camden lock, 30 jamestown road, camden, nw1 7by, london United Kingdom Duyuru • Jun 05
Dr. Martens plc Announces Executive Changes Dr. Martens plc announced that Katherine Bellau has been appointed as Company Secretary with effect from 3 June 2024. Katherine succeeds Emily Reichwald, who will be taking up a different role within the business. Duyuru • Jun 02
Dr. Martens plc Proposes Final Dividend for Fiscal Year Ended 31 March 2024, Payable on 1 October 2024 The board of Dr. Martens plc has proposed, subject to shareholder approval, a final dividend of 0.99 pence (fiscal year 2023: 4.28 pence), taking the total dividend for fiscal year ended 31 March 2024, including the interim dividend of 1.56 pence, to 2.55 pence, a 35% payout ratio. Whilst this is a year-on-year reduction given the higher payout in fiscal year 2023 and lower earnings achieved 2024, the 35% payout for fiscal year 2024 is at the top of the policy range. The board's intention is to hold the fiscal year 2025 dividend flat in absolute terms, before returning to an earnings payout in line with its dividend policy (of 25% to 35% payout) in fiscal year 2026 onwards. The final dividend for fiscal year 2024 will be paid to shareholders on the register as at 30 August 2024 with payment on 1 October 2024. Duyuru • May 21
Marathon Partners Urges Dr. Martens to Buy Back Stock On May 20, 2024, Marathon Partners Equity Management announced that it is turning up the heat on Dr. Martens plc by urging the Company to detail planned expense cuts and to buy back stock. Duyuru • Apr 17
Dr. Martens plc Announces CEO Changes Dr. Martens plc announced that Kenny Wilson has decided that this will be his final year as Chief Executive Officer (CEO) of the Company. As part of an orderly succession plan, and following a thorough search process, the Board announced that Ije Nwokorie, currently Chief Brand Officer (CBO), will succeed Kenny as CEO. Kenny and Ije will work together to ensure a smooth handover, with Ije becoming CEO before the end of the current financial year. Ije will remain as CBO in the meantime, with his focus being on the brand and driving demand ahead of the important AW24 season. Ije Nwokorie was a Non-Executive Director on the Board from January 2021 until early 2024, when he joined the business as Chief Brand Officer, with responsibility for product, marketing and strategy. Ije was previously at Apple Inc, where he was Senior Director, Apple Retail from January 2018. Prior to this he spent 11 years at global brand consultancy Wolff Olins, where he was latterly CEO, leading teams in offices in San Francisco, London, Dubai and New York. He is currently also Chair of water UK. Duyuru • Apr 03
Marathon Partners Calls for Strategic Review Process for Dr. Martens On April 2, 2024, Marathon Partners Equity Management, LLC and its affiliated investment funds announced that they recently delivered a letter to Chairman Paul Mason and the Board of Directors, urging the Board to commence a process of evaluating alternatives to maximize shareholder value, including a potential sale of Dr. Martens plc. In the letter to the Board, Marathon Partners recommended that the Company’s Board hire an advisor and commence a strategic review process, including a potential sale or merger of the Company to interested parties, with the express goal of maximizing shareholder value. Marathon Partners stated that prior to the release of its letter, it held discussions with multiple Directors of the Company to privately resolve these matters. Marathon Partners also stated that while these conversations were friendly and productive, they did not lead to a satisfactory resolution of important shareholder issues. Duyuru • Feb 27
Giles Wilson to Join Dr. Martens plc as CFO on May 27, 2024 Dr. Martens plc announced that Giles Wilson, who has been appointed to the role of Chief Financial Officer (CFO), will join the business and Board on 27th May 2024 and will present the fiscal year 2024 results on 30th May 2024. Duyuru • Nov 30
Dr. Martens plc Approves Interim Dividend, Payable on 2 February 2024 Dr. Martens plc has approved and the Company has declared an interim dividend of 1.56p per share (2023: 1.56 pence). The interim dividend will be paid to shareholders on the register as at 5 January 2024 with payment on 2 February 2024. Duyuru • Nov 14
Dr. Martens plc to Report Fiscal Year 2024 Results on May 30, 2024 Dr. Martens plc announced that they will report fiscal year 2024 results on May 30, 2024 Duyuru • Jan 19
Dr. Martens plc Provides Revenue Guidance for Fiscal Year 2023 Dr. Martens plc provided revenue guidance for fiscal year 2023. For the period, revenue growth for the revenue on an actual currency basis will now be 11%-13% (4-6% CC). Duyuru • Jul 14
Dr. Martens plc to Report Fiscal Year 2023 Results on Jun 01, 2023 Dr. Martens plc announced that they will report fiscal year 2023 results on Jun 01, 2023